n-(1-methyl-2-phenylethyl)adenosine has been researched along with morphine in 4 studies
| Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (morphine) | Trials (morphine) | Recent Studies (post-2010) (morphine) |
|---|---|---|---|---|---|
| 134 | 0 | 4 | 44,270 | 5,200 | 8,695 |
| Protein | Taxonomy | n-(1-methyl-2-phenylethyl)adenosine (IC50) | morphine (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.2939 | |
| Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2278 | |
| Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0828 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0385 | |
| Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0545 | |
| Mu-type opioid receptor | Homo sapiens (human) | 0.122 | |
| Delta-type opioid receptor | Homo sapiens (human) | 0.1199 | |
| Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.9308 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.655 | |
| Mu-type opioid receptor | Mus musculus (house mouse) | 0.3305 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.202 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.25 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, JX; Sollevi, A; von Heijne, M; Wiesenfeld-Hallin, Z; Xu, XJ; Yu, W | 1 |
| Naghipour, B; Roushan-zamir, F; Shafaghi, B; Zarrindast, MR | 1 |
| Hao, JX; Sollevi, A; von Heijne, M; Xu, XJ | 1 |
| Homayoun, H; Khavandgar, S; Torkaman-Boutorabi, A; Zarrindast, MR | 1 |
4 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and morphine
| Article | Year |
|---|---|
Reduced anti-allodynic effect of the adenosine A1-receptor agonist R-phenylisopropyladenosine on repeated intrathecal administration and lack of cross-tolerance with morphine in a rat model of central pain.
Topics: Adenosine; Analgesics; Analgesics, Opioid; Animals; Chronic Disease; Drug Tolerance; Female; Injections, Spinal; Morphine; Pain; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Spinal Cord Injuries | 1998 |
Effects of adenosine receptor agents on the expression of morphine withdrawal in mice.
Topics: Adenosine; Analysis of Variance; Animals; Behavior, Animal; Diarrhea; Male; Mice; Mice, Inbred Strains; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Substance Withdrawal Syndrome; Theobromine; Xanthines | 1999 |
Effects of intrathecal morphine, baclofen, clonidine and R-PIA on the acute allodynia-like behaviours after spinal cord ischaemia in rats.
Topics: Adenosine; Adrenergic alpha-Agonists; Analgesics, Opioid; Animals; Baclofen; Behavior, Animal; Clonidine; Female; GABA Agonists; Injections, Spinal; Ischemia; Morphine; Neuralgia; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sodium Chloride; Spinal Cord | 2001 |
The effects of adenosine receptor agonists and antagonists on morphine state-dependent memory of passive avoidance.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Analgesics, Opioid; Animals; Learning; Male; Memory; Mice; Morphine; Receptors, Purinergic P1; Theophylline; Vasodilator Agents | 2002 |